ClinicalTrials.Veeva

Menu

Percutaneous Transhepatic Intrahepatic Portosystemic Shunt for Treatment of Portal Vein Occlusion With Symptomatic Portal Hypertension After Splenectomy

Sun Yat-sen University logo

Sun Yat-sen University

Status

Unknown

Conditions

Hypertension, Portal
Portal Vein, Cavernous Transformation Of

Treatments

Procedure: Percutaneous transhepatic intrahepatic portosystemic shunt

Study type

Interventional

Funder types

Other

Identifiers

NCT02505152
PTIPSDORNO3HSYSU

Details and patient eligibility

About

To evaluate the values of percutaneous transhepatic intrahepatic portosystemic shunt for treatment of portal vein occlusion with symptomatic portal hypertension after splenectomy.

Enrollment

50 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients with portal hypertension who have the history of splenectomy and have enough image information to confirm occlusion of portal vein

Exclusion criteria

  • Patients with known severe dysfunction of heart, lung, brain, kidney and other vital organs

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

Shunt
Experimental group
Description:
Perform percutaneous transhepatic intrahepatic portosystemic shunt
Treatment:
Procedure: Percutaneous transhepatic intrahepatic portosystemic shunt

Trial contacts and locations

1

Loading...

Central trial contact

Zaibo Jiang, MD.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems